tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ALX Oncology Holdings: Strategic Focus and Promising Developments Drive Buy Rating
PremiumRatingsALX Oncology Holdings: Strategic Focus and Promising Developments Drive Buy Rating
2M ago
ALX Oncology Advances Cancer Therapy Pipeline
Premium
Company Announcements
ALX Oncology Advances Cancer Therapy Pipeline
2M ago
ALX Oncology Appoints Dr. Curran to Board
Premium
Company Announcements
ALX Oncology Appoints Dr. Curran to Board
2M ago
ALX Oncology highlights preclinical data, development plans for ALX2004
PremiumThe FlyALX Oncology highlights preclinical data, development plans for ALX2004
5M ago
Strategic Shift and Promising Pipeline Drive Buy Rating for ALX Oncology Holdings
Premium
Ratings
Strategic Shift and Promising Pipeline Drive Buy Rating for ALX Oncology Holdings
5M ago
ALX Oncology price target lowered to $2 from $5 at H.C. Wainwright
Premium
The Fly
ALX Oncology price target lowered to $2 from $5 at H.C. Wainwright
5M ago
ALX Oncology reports ASPEN-03, ASPEN-04 trials did not meet primary endpoints
PremiumThe FlyALX Oncology reports ASPEN-03, ASPEN-04 trials did not meet primary endpoints
6M ago
ALX Oncology receives IND clearance from FDA for ALX2004
Premium
The Fly
ALX Oncology receives IND clearance from FDA for ALX2004
6M ago
ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating
Premium
Ratings
ALX Oncology Holdings: Balancing Growth Potential and Uncertainty with a Hold Rating
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100